Search results
Results from the WOW.Com Content Network
Amylin Pharmaceuticals, Inc. is a biopharmaceutical founded in 1987 that was based in San Diego, California. The company was engaged in the discovery, development, and commercialization of drug candidates for the treatment of diabetes , obesity , and other diseases.
News that Amylin Pharmaceuticals (AMLN) inked a billion-dollar development deal with Takeda Pharmaceutical for new obesity therapies was among the favorable developments in the sector on Monday ...
Amylin Pharmaceuticals' (NAS: AMLN) investors were able to breathe a sigh of relief on Friday, when the Food and Drug Administration approved the company's diabetes drug, Bydureon. Finally. This ...
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares ...
Amylin Pharmaceuticals; Apricus Biosciences; ... Notable companies and corporations headquartered outside San Diego, but within San Diego County include: Apparel.
Pramlintide (trade name Symlin) is an injectable amylin analogue drug for diabetes (both type 1 and 2), developed by Amylin Pharmaceuticals (now a wholly owned subsidiary of AstraZeneca). [1] Pramlintide is sold as an acetate salt.
Bloomberg, the exclusive media outlet of Amylin Pharmaceuticals' (NAS: AMLN) rumor-leaking department, published a report on Friday that Sanofi and Merck (NYS: MRK) have put in bids to buy the ...
More than 50 San Diego companies trace their lineage directly to Hybritech, its founders and early employees. Among those are IDEC, San Diego's biggest biotech success story, with a billion dollars in sales for its lymphoma treatment Rituxan. Others include Amylin, Cancervax, Gen-Probe, Ligand Pharmaceuticals and Nanogen. [9]